The Latest Cardiac and Vascular News
MONTREAL, June 23, 2023 (GLOBE NEWSWIRE) — The Montreal Heart Institute (MHI) welcomes the approval by the United States Food and Drug Administration (FDA) of colchicine for cardiovascular prevention. Low-dose colchicine (0.5 mg once daily) is the first approved anti-inflammatory medication to reduce the risk of myocardial infarction (heart attack), […]
BURLINGTON, Mass., June 23, 2023 (GLOBE NEWSWIRE) — scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that it expects to be added to the small […]
MINNEAPOLIS, June 22, 2023 (GLOBE NEWSWIRE) — CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that it is set to join the Russell 2000 Index and the broad-market Russell 3000 Index at […]
Oak Ridge, TN, June 22, 2023 (GLOBE NEWSWIRE) — Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announced that Maxim Group LLC (“Maxim”), as Representative of several Underwriters of its previously announced secondary public offering have partially exercised their option to purchase an additional 54,339 Option Shares […]
MONTREAL–(BUSINESS WIRE)–Jubilant DraxImage Inc., dba Jubilant Radiopharma, a wholly-owned subsidiary of Jubilant Pharma Limited, is pleased to announce the clearance by the FDA to use its RUBY Rubidium Elution System™ and RUBY-FILL® (Rubidium Rb82 generator) in mobile settings. RUBY-FILL is used for cardiac PET imaging under rest or pharmacologic stress conditions to […]
Colchicine’s Approval Heightens the Need for Technologies Detecting Inflammation Specifically Related to Coronary Arteries OXFORD, England, June 22, 2023 /PRNewswire/ — Caristo Diagnostics Limited, a global leader in cardiac and vascular disease diagnostics and risk prediction, applauds the FDA’s decision to approve colchicine as first anti-inflammatory drug for cardiovascular disease. Caristo reaffirms its commitment […]
Interventional study to evaluate long term outcomes of Volta’s AI solution-supported ablation in recurrent-AF patients who failed previous ablation International, multi-center trial at 21 sites with results expected in 2025 MARSEILLE, France, June 22, 2023 (GLOBE NEWSWIRE) — Volta Medical, a pioneering health technology company developing artificial intelligence (AI) solutions […]
Received Grant of Protection for a Design Patent in Japan Covering its Innovative LIBERTY® Robotic Drive HINGHAM, Mass., June 22, 2023 (GLOBE NEWSWIRE) — Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY® Robotic Surgical System, the first single-use endovascular robotic surgical system, today announced the expansion of its global […]
PARIS–(BUSINESS WIRE)–Pioneering smart medical device company, Sensome, and world-leading Japanese guidewire company, Asahi Intecc, are announcing today a collaboration to develop the next generation Clotild® Smart Guidewire, with Asahi Intecc taking on the manufacturing role for this groundbreaking device destined for the treatment of acute ischemic stroke. Acute ischemic stroke is […]
Alliance further strengthens Philips’ industry-leading SymphonySuite solution, a complete, integrated offering to support clinicians or hospitals to open and operate office-based labs and ambulatory surgery centers Addition of BIOTRONIK’s cardiovascular technologies and products to the Philips SymphonySuite device programs expands the volume of procedures clinicians can perform in out-of-hospital settings, […]
